The inflammatory activity in the body caused by rheumatoid arthritis is linked to specific cognitive impairments, finds a small comparative study, published in the open access journal RMD Open.
BridgeBio’s $250M offering; ViiV’s PhI data for ultra-long-acting HIV treatment
Plus, news about Viking Therapeutics, Arcutis Biotherapeutics, Akari and Peak Bio: BridgeBio’s stock sale: The company announced plans to raise $250 million the same day